| Bioactivity | Pemvidutide (TFA) is a GLP-1R/GCGR dual agonist, shows striking reductions in body weight, liver fat and serum lipids. Pemvidutide can be used in non-alcoholic steatohepatitis (NASH) and obesity research[1]. |
| Name | Pemvidutide TFA |
| Formula | C182H275N39O54.xC2HF3O2 |
| Molar Mass | 3873.35 (free base) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yabut JM, et al. Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease. Endocr Rev. 2022 Jul 30:bnac018. |
Pemvidutide TFA
CAS: F: C182H275N39O54.xC2HF3O2 W: 3873.35 (free base)
Pemvidutide (TFA) is a GLP-1R/GCGR dual agonist, shows striking reductions in body weight, liver fat and serum lipids. P
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.